Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Lexaria Bioscience Corp. (LEXX) had Earnings per Share (EPS) (Basic) of $-0.07 for the most recently reported fiscal quarter, ending 2025-11-30.
| Income Statement Financials | |
-- |
|
$-1.59M |
|
-- |
|
-- |
|
$1.57M |
|
$-1.57M |
|
$-0.02M |
|
$-1.60M |
|
$-1.57M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.58M |
|
$-1.57M |
|
$-1.56M |
|
21.38M |
|
21.38M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.07 |
$-0.07 |
|
| Balance Sheet Financials | |
$5.36M |
|
$0.22M |
|
$0.69M |
|
$6.05M |
|
$1.46M |
|
-- |
|
$0.07M |
|
$1.53M |
|
$4.52M |
|
$4.22M |
|
$4.52M |
|
22.23M |
|
| Cash Flow Statement Financials | |
$-0.98M |
|
$-0.01M |
|
$3.47M |
|
$1.80M |
|
$4.28M |
|
$2.48M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.32% |
|
-37.90% |
|
-26.40% |
|
-35.32% |
|
$0.20 |
|
$-0.05 |
|
$-0.05 |
|